It was billed as “an evening of candor and compassion,” but with onetime M*A*S*H screenwriter Neil Senturia serving as impresario, a San Diego forum on business failure became an extended tragic-comic riff, abounding with one-liners. Entrepreneurs are rarely willing to publicly discuss their failures after they shut a company down, perhaps with the exception of … Continue reading “A Forum on Failure Stirs One-Liners and Personal Anguish Among CEOs”
Massachusetts, Washington Top Kauffman Foundation’s List of “New Economy” States
In a report released Tuesday, the Information Technology and Innovation Foundation (ITIF) and the Ewing Marion Kauffman Foundation named Massachusetts the nation’s leading state when it comes to the structural economic factors that make the state’s businesses competitive in the “New Economy”—defined as global, entrepreneurial, knowledge-based, rooted in information technologies, and innovation-driven. Massachusetts hung onto … Continue reading “Massachusetts, Washington Top Kauffman Foundation’s List of “New Economy” States”
Bsquare Founder Bill Baxter Comments on TestQuest Acquisition—Sees Marginal Benefit
This morning, there was news about Bellevue, WA-based Bsquare buying the assets of TestQuest, a Minneapolis, MN-based mobile software firm, for $2.2 million. It made me think about the strategy behind the deal, and whether it signifies a shift in Bsquare’s business. So I pinged Bill Baxter, who founded Bsquare as CEO in 1994 and … Continue reading “Bsquare Founder Bill Baxter Comments on TestQuest Acquisition—Sees Marginal Benefit”
Selling the Game
Okay, your game is cool, but can you sell it? The MIT Enterprise Forum Interactive Entertainment SIG is getting together a panel of gamers and marketers to guide you on how to bring your games or technologies to market and what they have learned along the way. It’s all in knowing how to play the … Continue reading “Selling the Game”
Bsquare Buys TestQuest for $2.2M
Bellevue, WA-based Bsquare (NASDAQ: [[ticker:BSQR]]) announced today it has acquired the assets of TestQuest, a mobile test automation and management company based in Minneapolis, MN. The purchase price is about $2.2 million. The acquisition helps Bsquare, which makes software for smart devices, add new customers in the U.S., Asia, and Europe.
From Virtual Threads to Polar Bear Cubs: MITX Honors Region’s Top Web Marketing Campaigns
The Massachusetts Innovation & Technology Exchange (MITX), the industry association for Boston-area digital media and marketing companies, handed out its 13th annual “Interactive Awards” last night in a ceremony at the Boston Marriott Copley Place hotel. A kind of multimedia version of the national Clio awards, but recognizing the years’ most creative advertising campaigns by … Continue reading “From Virtual Threads to Polar Bear Cubs: MITX Honors Region’s Top Web Marketing Campaigns”
Adimab Closes Third VC Round
Adimab, a Lebanon, NH-based biotech firm focused antibody discovery, says it has closed a Series C round of financing from new investors OrbiMed Advisors, Borealis Ventures, and return backers Polaris Venture Partners and SV Live Sciences. Financial details weren’t disclosed. Tillman Gerngross, CEO and co-founder of the company, said in a statement that his company … Continue reading “Adimab Closes Third VC Round”
Radius Adds $15M to Series C
Radius Health, a Cambridge, MA-based developer of drugs for osteoporosis and women’s health, says it has added $15 million more to its Series C round of venture capital, which now totals $82.5 million, with investments from MPM Capital, the Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures, and Scottish Widows Investment Partnership. The … Continue reading “Radius Adds $15M to Series C”
Geospiza to Acquire VizX Labs’ Genesifter Technology For Genomic Data
Geospiza, a Seattle-based maker of software to help researchers keep track of massive amounts of genomic data, said today it has acquired the Genesifter technology created by Seattle-based VizX Labs. Terms of the acquisition weren’t disclosed. Geospiza president Rob Arnold said in a statement that the acquisition will enable his company to speed up expansion … Continue reading “Geospiza to Acquire VizX Labs’ Genesifter Technology For Genomic Data”
Immune Design Obtains Vaccine Booster From IDRI
Immune Design, the Seattle-based vaccine development company, has obtained a worldwide exclusive license to develop a vaccine-boosting compound invented at the Infectious Disease Research Institute (IDRI). The technology, a glycopyranosyl lipid adjuvant, may be used to enhance the effectiveness of vaccines. The nonprofit IDRI will receive an upfront payment, milestone payments on success in testing, … Continue reading “Immune Design Obtains Vaccine Booster From IDRI”
Staccato Marries Artimi, Gets $20M Burst
Will it be a match made in ultra wideband heaven? San Diego-based Staccato Communications says it has merged with another ultra wideband semiconductor developer, Artimi, and raised $20 million in equity financing from previous investors in both companies. The company, which will keep the Staccato name, says the combination of Staccato’s wireless semiconductors and Mountain … Continue reading “Staccato Marries Artimi, Gets $20M Burst”
Idera and Merck Extend R&D Deal
Idera Pharmaceuticals (NASDAQ:[[ticker:IDRA]]), a Cambridge, MA-based developer of drugs that target a family of immune system receptors, reports it has inked a one-year extension to its research collaboration with New Jersey-based drug giant Merck. The two companies began the collaboration in December 2006 to investigate Idera’s drugs as treatments for cancer, infectious diseases, and Alzheimer’s.
Got Dry Eye? Take Fish Oil. Resolvyx Moves First Compound Into Human Test
Resolvyx Pharmaceuticals is eying the ophthalmic market. The Bedford, MA-based biotech firm plans to announce today that the first human clinical tests of its resolvins—compounds with anti-inflammatory properties that occur naturally in fish oil—will be in patients with dry eye syndrome. Mind you, many initial clinical trials are done with small pools of 40 or … Continue reading “Got Dry Eye? Take Fish Oil. Resolvyx Moves First Compound Into Human Test”
Shire HGT Adds 150 Mass. Workers, Genetic Therapy Sales Soar, President Says
We in Massachusetts don’t read as much about Shire Human Genetic Therapies (HGT) as other large biotech organizations headquartered here like Genzyme (NASDAQ:[[ticker:GENZ]]) and Biogen Idec (NASDAQ:[[ticker:BIIB]]). Why? Well, for one thing, Shire HGT is a unit of Irish specialty drug company Shire. (The division was formed through Shire’s $1.6 billion acquisition of Cambridge, MA-based … Continue reading “Shire HGT Adds 150 Mass. Workers, Genetic Therapy Sales Soar, President Says”
Mayonnaise Wrestling, Flavor Fanaticism, and Social Media on Steroids: The Bacon Salt Story
Sometimes the best stories are the hardest to tell. This isn’t one of them. I’m not quite sure where to begin, but here goes. There is a startup in South Seattle called Bacon Salt. Maybe you’ve heard of it, maybe you haven’t. But the name says it all: Bacon Salt is a zero-calorie, vegetarian, kosher … Continue reading “Mayonnaise Wrestling, Flavor Fanaticism, and Social Media on Steroids: The Bacon Salt Story”
Wireless Industry’s CDMA True Believers Chart CDMA’s Future for CDMA crowd
The phrase “preaching to the choir” came to mind as I listened to the speakers today at the 3G CDMA North America Regional Conference, which is being held this year in downtown San Diego at the U.S. Grant Hotel. Seated in the audience around me were representatives of wireless carriers, equipment makers and device venders … Continue reading “Wireless Industry’s CDMA True Believers Chart CDMA’s Future for CDMA crowd”
Seattle’s Pharma Godfather, Vaccine Impresario Re-Emerges, Accelerator Gets New Investor & More Seattle-Area Life Sciences News
We scored exclusive interviews with a couple of biotech industry leaders this week, and heard their views on some of the most intriguing technologies they see emerging in Seattle and around the world. —Former Merck research leader Bennett Shapiro, who lives in a waterfront home in Seattle’s Magnolia neighborhood, explained why he thinks life sciences … Continue reading “Seattle’s Pharma Godfather, Vaccine Impresario Re-Emerges, Accelerator Gets New Investor & More Seattle-Area Life Sciences News”
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
The news was mostly good for Boston-area life sciences firms this past week, with some money raised, some deals done, and some intriguing new technologies unveiled. —Luke talked to Tod Woolf, CEO of RXi Pharmaceuticals (NASDAQ: [[ticker:RXII]]), about the tremendous challenge of delivering RNAi-based drugs—and how the Worcester, MA-based firm plans to overcome it. Its … Continue reading “RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News”
Radius Health, Inc. Receives $15,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e6ffffa1-53cd-454c-b10b-a8986bc91a8b&Preview=1 Date 11/20/2008 Company Name Radius Health, Inc. Mailing Address 300 Technology Square, Fifth Floor Cambridge, MA 02139 Company Description Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. Website http://www.radiuspharm.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction … Continue reading “Radius Health, Inc. Receives $15,000,000 Series C Round”
Adimab, Inc. Receives Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea916dda-1b46-4da8-97cb-a8ce2fed1381&Preview=1 Date 11/20/2008 Company Name Adimab, Inc. Mailing Address 16 Cavendish Court Lebanon, NH 03766 Company Description Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners. Website http://www.adimab.com Transaction Type … Continue reading “Adimab, Inc. Receives Series C Funding Round”
Staccato Communications, Inc. Receives $20,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8747121-230b-44a5-8925-9a92f73b92de&Preview=1 Date 11/20/2008 Company Name Staccato Communications, Inc. Mailing Address 6195 Lusk Blvd San Diego, CA 92121 Company Description Staccato Communications is a fabless semiconductor company based in San Diego, Calif., and founded by industry pioneers who have developed ultrawideband (UWB) technology and high-speed CMOS RF technology since 1996. Website http://staccatocommunications.com Transaction … Continue reading “Staccato Communications, Inc. Receives $20,000,000 New Financing”
Aprius Receives $20,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4e8dd5a-686c-4a84-9e77-38a81e5f464b&Preview=1 Date 11/20/2008 Company Name Aprius Mailing Address 440 North Wolfe Road Sunnyvale, CA 94085 Company Description The company is developing technology in the high-speed computer interconnect field. Website http://www.aprius.com Transaction Type Venture Equity Transaction Amount $20,000,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Aprius Receives $20,000,000 Series B Round”
Pacific BioSciences Garners $20,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba4d1dd9-46b9-4610-809d-8ef709abc2d4&Preview=1 Date 11/20/2008 Company Name Pacific BioSciences Mailing Address 1505 Adams Drive Menlo Park, CA 94025 Company Description The company is focused on developing treatments for various diseases through gene sequencing therapies. Website http://www.pacificbiosciences.com Transaction Type Venture Equity Transaction Amount $20,000,000 Transaction Round Undisclosed Proceeds Purposes These funds will be used to … Continue reading “Pacific BioSciences Garners $20,000,000 New Financing Round”
Real Girls Media Network Receives Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=20d9e1e5-b938-4fe5-9a74-ae1ca6e2b7d9&Preview=1 Date 11/20/2008 Company Name Real Girls Media Network Mailing Address 575 Market St. San Francisco, CA 94105 Company Description Real Girls Media Network, Inc., a digital network created for women, by women, is a San Francisco-based, privately held company backed by 3i and Walden Ventures. Website http://www.realgirlsmedia.com Transaction Type Venture Equity … Continue reading “Real Girls Media Network Receives Series B Financing”
Datacastle Closes $5.3M Series A Financing, Gets New Leadership
It’s been a busy week for data-protection companies around here. Two days after Decho was formed out of Seattle-based Pi and Utah-based Mozy, information security firm Datacastle of Seattle has announced a $5.3 million Series A financing round. The investment was led by the Australian venture firm CM Capital Investments. No other investors were disclosed. … Continue reading “Datacastle Closes $5.3M Series A Financing, Gets New Leadership”
Akamai to Cut 110 Workers Worldwide
Akamai Technologies (NASDAQ:[[ticker:AKAM]]) is contributing to our growing list of local tech firms laying off workers recently, saying it will cut about 110 employees or 7 percent of its total staff this quarter to reduce operating costs. But the Cambridge, MA-based company, which operates a worldwide network of servers that speed delivery of its clients’ … Continue reading “Akamai to Cut 110 Workers Worldwide”
Targanta Antibiotic Shot Down By FDA Panel
(Update: The fourth paragraph includes a statement from Targanta about the panel’s vote.) Targanta Therapeutics was dealt a blow late this afternoon. A panel of expert advisers to the FDA voted by a 10-8 margin that the Cambridge, MA-based company’s experimental antibiotic for complex skin infections hasn’t yet shown enough evidence that it’s safe and … Continue reading “Targanta Antibiotic Shot Down By FDA Panel”
Carlsbad’s Aptera to Compete for $10 Million Automotive X Prize
Twenty-two teams of aspiring automakers, including Carlsbad-based Aptera, have registered so far to compete for $10 million in prizes offered as part of a “Great Race” to develop super fuel-efficient vehicles, the Progressive Automotive X Prize said today. Aptera, which began development of a futuristic-looking three-wheel passenger car five years ago, is among the teams … Continue reading “Carlsbad’s Aptera to Compete for $10 Million Automotive X Prize”
2008 New England Venture Summit
As if the economy wasn’t exciting enough as is, this one-day summit culminates with a VC Smackdown—an exciting debate format between VCs and entrepreneurs centering on issues in financings and deals that get under their skin. Before that, topics touch on early-stage funding, presentations by startups, and exit strategies. Presented by youngStartup Ventures.
Information and Communications Technology at Greenbuild: The Springboard for Innovation and Execution
Interactive panel of experts on lessons learned from The Greenbuild International Conference and Expo on the future of information and communication technologies (ICT) in green building. The role of ICT is a consistent thread throughout Greenbuild, from new teaching tools and performance measurements, through interactive technologies, real-time response, and the vast array of ICT tools that … Continue reading “Information and Communications Technology at Greenbuild: The Springboard for Innovation and Execution”
In-Q-Tel Invests in Febit
Febit, a Heidelberg, Germany-based maker of automated, microfluidic gene and RNA sequencing devices with laboratories in Lexington, MA, said today that In-Q-Tel, the venture wing of the U.S. intelligence community, has made a strategic investment in the company. The size of the investment was not disclosed, but In-Q-Tel’s investments usually range between $1 million and … Continue reading “In-Q-Tel Invests in Febit”
EnerNOC Wins Fed Business
Boston’s EnerNOC, which runs “demand-response pools” consisting of companies, municipalities, and other organizations that agree to dial back their electricity consumption during hours of peak demand, said today that it’s won permission to sign up U.S. federal and military facilities as pool participants. The Pentagons’ Defense Energy Support Center (DESC) formally approved EnerNOC as a … Continue reading “EnerNOC Wins Fed Business”
Avion, Kinetic Vehicles, and Western Washington University Compete for $10M Automotive X Prize
The Automotive X Prize in Los Angeles announced today it has chosen its first 22 teams to compete for $10 million in prizes that will be awarded for developing super fuel-efficient vehicles (100 miles per gallon or equivalent is the nominal goal). Among this first wave of contenders are three Northwest teams: Bellingham, WA-based Avion; … Continue reading “Avion, Kinetic Vehicles, and Western Washington University Compete for $10M Automotive X Prize”
Ambric Closes Down, Goes on Sale
Ambric, a Beaverton, OR-based semiconductor company, has announced it is shutting down and looking for a corporate buyer. The firm has suspended all operations not having to do with its sale or existing customer agreements. Ambric has developed software-programmable parallel processor chips that are used in video coding, wireless base stations, and medical and military … Continue reading “Ambric Closes Down, Goes on Sale”
Elixir Reports Positive Results in Late-Stage Clinical Trial for Diabetes Drug
Elixir Pharmaceuticals says it has the clinical data to support an application for approval of its combination drug for Type 2 diabetes—expected, as earlier announced, to be submitted to the FDA next year—based on positive results from a late-stage clinical trial and previous studies, according to a company statement. The Cambridge, MA-based biotech firm reports … Continue reading “Elixir Reports Positive Results in Late-Stage Clinical Trial for Diabetes Drug”
$7 Million for Rave
Rave Wireless, a Framingham, MA, startup that makes security and emergency alert software for mobile phones, has closed a $7 million Series D financing round, according to a November 15 report in PE Hub that cited regulatory filings. The report said Rave has now raised about $42 million, with major contributions from Bain Capital Ventures, … Continue reading “$7 Million for Rave”
Local Seattle News Site, Crosscut, May Switch to Nonprofit Model To Pay the Bills
One of Seattle’s best-known technology investors, Tom Alberg of Madrona Venture Group, had a conversation a couple years ago with David Brewster, the founding editor of Seattle Weekly, about how the Internet was transforming journalism. “Tom said, ‘Local news is a big opportunity, and online media is a big opportunity. Let’s brainstorm some ideas,’” Brewster … Continue reading “Local Seattle News Site, Crosscut, May Switch to Nonprofit Model To Pay the Bills”
Slydial Users Pass 1 Million Messages; We Test New Slydial iPhone App, Which Isn’t Always So Sly
Back in July I wrote two somewhat skeptical stories about Slydial, the free service that lets you leave voicemail messages for cell-phone users without causing their phones to ring. My problem wasn’t with the technology itself, but with the misanthropic way that MobileSphere, the Boston company that created Slydial, was marketing it. They were promoting … Continue reading “Slydial Users Pass 1 Million Messages; We Test New Slydial iPhone App, Which Isn’t Always So Sly”
Trade Group Looks for a Pause, Not a Downturn, in Digital Wireless Sector
As the CDG North America Regional Conference convenes in San Diego today, Perry LaForge, the trade association’s chief executive, says he has a lot to feel good about. LaForge says he started working on behalf of CDMA, or code-division multiple access, after getting a preview of the wireless technology in 1988, when San Diego’s Qualcomm … Continue reading “Trade Group Looks for a Pause, Not a Downturn, in Digital Wireless Sector”
Young Innovators Network Aims to Boost Leading-Edge Ideas at “‘The Hutch”‘
Get ’em while they’re young. It’s true of the folks who market breakfast cereals, and also in the world of philanthropy. The Fred Hutchinson Cancer Research Center has a reputation as a world-class research center, and it has no trouble enticing A-list Seattle businesspeople to join its board and open their checkbooks. Usually these people … Continue reading “Young Innovators Network Aims to Boost Leading-Edge Ideas at “‘The Hutch”‘”
TeachStreet Expands to Bay Area
Seattle-based TeachStreet announced today it has moved into the San Francisco Bay Area in a major expansion of its service, which helps local teachers and students connect with one another online. The company’s initial Bay Area site has more than 65,000 listings of classes, teachers, and experts in everything from aikido to yoga. TeachStreet, which … Continue reading “TeachStreet Expands to Bay Area”
Going Global: Ken Myer of WTIA Talks China Trip, Mobile Market, and Achievement Awards
Last month, Xconomy reported on a visit to China by five Seattle-area tech companies as part of a mobile-telecom mission organized by the Washington Technology Industry Association (WTIA). The goal of the trip was to open up business opportunities for the companies by setting up meetings with potential partners, investors, and customers. On Friday, I … Continue reading “Going Global: Ken Myer of WTIA Talks China Trip, Mobile Market, and Achievement Awards”
Biotech Analyst Runs For City Council
David Miller, the co-founder and CEO of Biotech Stock Research, an independent stock research firm in Seattle, has filed paperwork to run for the Seattle City Council. Miller plans to continue operating his stock newsletter throughout the campaign which ends in November 2009, and plans to keep the company operating if he wins, he and … Continue reading “Biotech Analyst Runs For City Council”
WBBA Hires Chris Rivera As President, Replacing Retiring Jack Faris
Chris Rivera, a longtime biotech industry executive with experience in sales and marketing, has been hired as the new president of the Washington Biotechnology & Biomedical Association, the state’s trade group for the life sciences industry. He will officially replace Jack Faris, who is retiring, on Jan. 1. “I feel a great sense of responsibility … Continue reading “WBBA Hires Chris Rivera As President, Replacing Retiring Jack Faris”
Former Athenahealth, RelayHealth Leaders Form Startup Maria Health, with Venrock Headlining Investor Group
A powerful anecdote about the ills of U.S. health care this past election season was about President-elect Barack Obama’s mother, who struggled to navigate the medical system while suffering from cancer, which eventually killed her in 1995. I was reminded of this a few days ago when I talked to Anshul Amar, chief technology officer … Continue reading “Former Athenahealth, RelayHealth Leaders Form Startup Maria Health, with Venrock Headlining Investor Group”
Qteros Garners $25,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2546a5af-f7f1-4243-b939-1bb13f51e46f&Preview=1 Date 11/19/2008 Company Name Qteros Mailing Address 100 Venture Way Hadley, MA 01035 Company Description Qteros began in 1996 with a walk near the Quabbin Reservoir in Western Massachusetts. University of Massachusetts microbiologist Dr. Susan Leschine and her lab assistant, Tom Warnick, were looking for a microbe that breaks down plant … Continue reading “Qteros Garners $25,000,000 Series B Funding Round”
Datacastle Garners $5,300,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7d52cbbc-8588-411a-9c8c-f0306dc1f50c&Preview=1 Date 11/19/2008 Company Name Datacastle Mailing Address 701 North 36th Street Seattle, WA 98103 Company Description Datacastle Corporation has a singular mission – to help organizations simply and cost effectively protect data against loss and laptop theft. We set out in 2005 to address the data protection challenges that expose organizations … Continue reading “Datacastle Garners $5,300,000 Series A Funding Round”
Apptera Garners $10,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=57c058ce-73e2-4cd9-81b9-5f100831d8f2&Preview=1 Date 11/19/2008 Company Name Apptera Mailing Address 1150 Bayhill Drive San Bruno, CA 94066 Company Description Apptera provides technology for mobile advertising, search and commerce. Our services are provided “In-Call” while a consumer is interacting with a business over the phone. These solutions are sold to companies looking to monetize their … Continue reading “Apptera Garners $10,500,000 New Financing Round”
Arete Therapeutics Secures $16,700,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=56e2be09-f935-4916-a20e-d54be3fa3ca2&Preview=1 Date 11/19/2008 Company Name Arete Therapeutics Mailing Address 7000 Shoreline Court South San Francisco, CA 94080 Company Description Arête Therapeutics Inc. is discovering and developing ‘first in class’ small molecule drugs directed at novel targets for cardiovascular diseases and inflammation. The Company’s proprietary therapies are directed at a new branch of … Continue reading “Arete Therapeutics Secures $16,700,000 Series A Funding Round”
Quantance Secures $12,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=143294c3-fa54-44ed-a1a0-dc9fca9edfc7&Preview=1 Date 11/19/2008 Company Name Quantance Mailing Address 2755 Campus Drive San Mateo, CA 94403 Company Description The company is developing semiconductor-based technologies. Website http://www.quantance.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Granite Ventures Venture Investor InterWest … Continue reading “Quantance Secures $12,000,000 Series B Funding”